NASDAQHealth CareDiagnostics & ResearchSnapshot 2026-07-31
Reading NOTV? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Management is running behind on a stated commitment.
View ThesisRevenue is growing steadily — about 6% over the past year.
View GrowthManagement screens weak on capital allocation, earnings delivery, the balance sheet, market reaction to earnings.
View ManagementThis stock is highly volatile — it swings about 6% on a typical day and fell roughly 100% in its worst 12-month stretch.
View RiskNOTV's growth depends on improving financial performance and sector trends. Recent results show a significant miss of 49%. The company trades at a low valuation compared to its peers. There is a 72% chance of another earnings miss next quarter. Peer multiples imply a price about 12% above where it trades. This read is provisional.
Trailing returns as of 2026-07-17. NOTV is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 1 analyst currently covering NOTV (as of Jun 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-08-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Life Sciences Tools & Services — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Threatens: Restructuring through Chapter 11 proceedings
Bankruptcy filing directly impacts restructuring efforts.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-17. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Advances: Manage financial obligations under Chapter 11
Debt reduction plan supports financial obligations management.
Threatens: Manage financial obligations under Chapter 11
Earnings miss indicates financial strain affecting obligations.
